Key facts
- Notable investors include Tech Incubator Program for Startup, InfoBank, Samsung Fire & Marine Insurance, iAccel (Seongnam-si).
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Neubreze
- ·The full record, as it builds
Funding rounds
No funding rounds for Neubreze are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Neubreze
Developer of digital healthcare devices intended to deliver technology tools to improve health management and patient outcomes. The company offers digital health products and services that are efficient, including a specialized focus on digital healthcare workflows, integration of clinical or wellness data into usable insights, and user-centric interfaces tailored for both medical professionals and patients, enabling healthcare providers, institutions, and health-conscious individuals to streamline health management.
- Sector
- Healthcare
- HQ
- Siheung, South Korea
- Founded
- 2024
- Website
- neubreze.com/
- Ownership
- Privately Held (backing)
Neubreze doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Neubreze shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Neubreze in its N-PORT filings yet. We sweep new filings monthly.